¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"antibiotic culture medium 12 FDA"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • enriched medium
    ¿µ¾ç°­È­¹èÁö
  • enrichment medium
    Áõ±Õ¹èÁö
  • isolation medium
    ºÐ¸®¹èÁö
  • intervening medium
    Áß°£¹èÁö
  • minimum essential medium
    ÃÖ¼ÒÇʼö¿µ¾ç¹èÁö
  • motility medium
    ¿îµ¿¼º¹èÁö
  • mounting medium
    ºÀÀÔÁ¦
  • medium
    1. ¹èÁö 2. ¸Åü 3. Áß°£
  • medium sized artery
    ÁßÇüµ¿¸Æ
  • nitrate medium
    Áú»ê¿°¹èÁö
  • nutrient medium
    ¿µ¾ç¹èÁö, º¸Åë¹èÁö
  • opaque medium
    ºÒÅõ°úÁ¶¿µÁ¦
  • overlay agar medium
    ¿ì¹«°ã¹èÁö
  • oxidation-fermentation medium
    »êÈ­¹ßÈ¿¹èÁö
  • solid medium
    °íÇü¹èÁö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • EMB agar medium
    ÀÌ¿¥ºñ¿ì¹«¹èÁö
  • enhancement medium
    Áõ°­¹èÁö
  • enriched medium
    ¿µ¾ç°­È­¹èÁö
  • enrichment medium
    Áõ±Õ¹èÁö
  • intervening medium
    Áß°£¸ÅÁú
  • isolation medium
    ºÐ¸®¹èÁö
  • medium
    ¹èÁö
  • minimum essential medium
    ÃÖ¼ÒÇʼö¿µ¾ç¹èÁö
  • motility medium
    ¿îµ¿¼º¹èÁö
  • mounting medium
    ºÀÀÔÁ¦
  • nitrate medium
    Áú»ê¿°¹èÁö
  • nutrient medium
    ¿µ¾ç¹èÁö, º¸Åë¹èÁö
  • opaque medium
    ºÒÅõ°úÁ¶¿µÁ¦
  • overlay agar medium
    ¿ì¹«°ã¹èÁö
  • oxidation-fermentation medium
    »êÈ­¹ßÈ¿¹èÁö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Bordet-Gengou medium
    º¸¸£µ¥-À屸¹èÁö
  • Dubos medium
    µÚº¸¹èÁö
  • EMB agar medium
    EMB ÇÑõ¹èÁö
  • Eagle medium
    À̱۹èÁö.
  • Endos medium
    ¿£µµ¹èÁö
  • Fetchers medium
    Ç÷¹Ã³¹èÁö
  • Fletcher medium
    Ç÷¹Ã³¹èÁö
  • Gruft medium
    ±¸·çÇÁÆ®¹èÁö
  • HAT medium
    HAT¹èÁö
  • Hugh-Leifson medium
    ÈÞ-¶óÀÔ½¼ ¹èÁö
  • Levinthals agar medium
    ·¹ºóÅ» ÇÑõ¹èÁö
  • Loefflers coagulated serum medium
    ·ÚÇ÷¯ÀÀ°íÇ÷û»ç¸é¹èÁö
  • Lowenstein-Jensen-Gruft medium
    ·Úº¥½ºÅ¸ÀÎ-¿£¼¾-±×·çÇÁÆ® ¹èÁö
  • MR-VP medium
    MR-VP ¹èÁö
  • Mitchison medium
    ¹ÌÄ¡½¼¹èÁö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • resistance to antibiotic
    Ç×»ýÁ¦ÀúÇ×¼º(ù÷ßæð¥î½ù÷àõ), Ç×»ýÁ¦³»¼º(ù÷ßæð¥ Ò±àõ).
  • standard antibiotic
    Ç¥ÁØÇ×»ý¹°Áú(¡­ù÷ßæ Úªòõ).
  • thiazolidone antibiotic
    Ƽ¾ÆÁ¹¸®µ·Ç×»ýÁ¦(¡­ù÷ßæð¥).
  • topical antibiotic
    ±¹¼Ò Ç×»ýÁ¦
  • agar medium
    ÇÑõ¹èÁö(ùÎô¸ÛÆò¢).
  • agar medium, overlay
    ÇÑõÁßÃþ¹èÁö
  • agar medium, semisolid
    ¹Ý°íÇüÇÑõ¹èÁö
  • american Thoracic Society medium
    ¹Ì±¹¤¾ºÎÇÐȸ¹èÁö
  • artery,medium muscular
    ±ÙÀ°¼º Áßµ¿¸Æ(ÐÉë¿àõñéÔÑØæ)
  • barium contrast medium
    ¹Ù·ý Á¶¿µÁ¦
  • basal medium
    ±âÃʹèÁö(Ðñõ¨ÛÆò¢).
  • basal medium
    ±âÃʹèÁö(Ðñõ¨ÛÆò¢).
  • bile-esculin medium
    ´ãÁó-¿¡½ºÄ𸰹èÁö
  • blood agar medium
    Ç÷¾×ÇÑõ¹èÁö(¡­ùÎô¸ÛÆò¢).
  • chemically defined medium
    ÇÕ¼º¹èÁö
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • enrichment medium
    º¸°­ ¹èÁö (ÜÍË­ÛÆò¢)
  • growth medium
    ¼ºÀå¹èÁö (à÷íþÛÆò¢)
  • HAT medium
    HAT ¹èÁö(ÛÆò¢)
  • inhibitory medium
    "ÀúÇØ ¹è¾ç¾×(îÁúªÛÆå×äû), ÀúÇØ ¹èÁö(îÁúªÛÆò¢)"
  • liquid medium
    ¾×ü¹èÁö(äûô÷ÛÆò¢)
  • maximal medium
    ÃÖ´ë¹èÁö(õÌÓÞÛÆò¢)
  • medium-chain fatty acid thiokinase
    Áß(ñé)»ç½½ Áö¹æ»ê(ò·Û¸ß«) Ä¡¿ÀÄ«À̳×À̽º
  • minimal medium
    ÃÖ¼Ò¹èÁö(õÌá³ÛÆò¢)
  • nutrient medium
    ¿µ¾ç¹èÁö(ç½å×ÛÆò¢)
  • selected medium
    "¼±ÅùèÁö(àÔ÷ÉÛÆò¢), ¼±Åà ¹è¾ç¾×(àÔ÷ÉÛÆå×äû)"
  • solid medium
    °íÇü¹èÁö(ͳû¡ÛÆò¢)
  • synthetic medium
    ÇÕ¼º ¹èÁö (ùêà÷ÛÆò¢)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
SCCM Sertoli cell culture medium; Society of Critical Care Medicine
TCM tissue culture medium; transcutaneous monitor
MSM medium-size molecule; mineral salts medium
SCM Schwann cell membrane; sensation, circulation, and motion; Society of Computer Medicine; soluble cyt...
TM technology management; tectorial membrane; temperature by mouth; temporalis muscle; temporomandibula...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MAR Multiple Antibiotic Resistance
OPAT Outpatient parenteral antibiotic therapy
PAE Post Antibiotic Effect
PA SME post-antibiotic sub-MIC effect
A.T.C.C. American Type Culture Collection
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • agar medium
    ÇÑõ ¹èÁö
  • alginate separating medium
    ¾ËÁö³×ÀÌÆ® ºÐ¸®Àç
  • barium contrast medium
    ¹Ù·ý Á¶¿µÁ¦
  • basal medium
    ±âÃÊ ¹èÁö
  • chemically defined medium
    ÇÕ¼º ¹èÁö
  • contrast medium
    Á¶¿µÁ¦
    ¾î¶² Á¶Á÷À̳ª °ø°£À» ¹æ»ç¼± ºÒÅõ°ú¼ºÀ¸·Î ¸¸µå´Â ¿µ»ó °Ë»ç¿¡ ¾Õ¼­ ÁÖ»çÇÏ´Â ¹æ»ç¼± ºÒÅõ°ú¼º ¹°Áú.
  • differential medium
    °¨º° ¹èÁö
  • Eagle`s minimal essential medium
    ÀÌ±Û ¹èÁö
    ¼¼Æ÷ ¹è¾ç¾×ÀÇ ÀÏÁ¾. 3Á¾·ùÀÇ ¾Æ¹Ì³ë»ê°ú 8Á¾·ùÀÇ ºñŸ¹ÎÀ» ÇÔÀ¯Çϰí ÀÖÀ¸¸ç º¸Åë Ç÷û 5% ÀÌÇÏ¿¡¼­ À¯Áö ¹èÁö·Î¼­ »ç¿ëµÇ°í 10-20%ÀÇ Ç÷û ÷°¡·Î ¸¹Àº ¼¼Æ÷´Â ±ØÈ÷ ¾çÈ£ÇÑ ¹ßÀ°À» ³ªÅ¸³½´Ù.
  • fluid cooling medium
    ¾×ü ³Ã¸Å
  • hypoxanthine-aminopterin-thymidine medium
    HAT ¹èÁö
  • marking liquid Ä¡Çü¿¡ ¹Ù¸¥ ÈÄ °ÇÁ¶µÇ¸é ÁÖÁ¶Ã¼¸¦ Ä¡Çü¿¡ ÀûÇÕ½ÃÄÑ ÁÖÁ¶Ã¼ ³»¸éÀÇ Á¶±â Á¢ÃËÁ¡À» ã´Â Àç·áÀÌ´Ù.

    marking medium

    ±³ÇÕÁö
    ÀÚ¿¬ Ä¡¾Æ¸¦ ¸ðÇü»ó¿¡¼­ »óÇÏ Ä¡¾Æ »çÀÌ¿¡ ³Ö°í ±³ÇÕ½ÃÄÑ Á¢Ã˰ü°è¸¦ °Ë»çÇÏ´Â ¸ÔÁö¿Í °°Àº °Í. µÎ²²°¡ ¾ã°í ±¤¹üÀ§ÇÏ°Ô ¹¯Áö ¾Ê´Â °ÍÀϼö·Ï ÁÁ´Ù. Á¤È­ÇÑ ±³ÇÕÀÇ ¼öÁý°ú ±³ÇÕ °£¼·À» Á¶Á¤Çϴµ¥ »ç¿ëµÈ´Ù.
  • medium fusing porcelain
    Áß¿ë µµÀç
  • medium-sized artery
    ÁßÇü µ¿¸Æ
  • minimum essential medium
    ÃÖ¼Ò Çʼö ¹èÁö
  • minimum medium
    ÃÖ¼Ò ¹èÁö, ÃÖ¼Ò ¿µ¾ç ¹èÁö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
medium-chain acyl-CoA dehydrogenase <enzyme> Deficiency in mitochondrial beta oxidation of fatty acids gives a disorder frequently masquerading as reye syndrome or sudden infant death; leads to buildup of octanoyl carnitine in urine
Registry number: EC 1.3.-
Synonym: mcaca-dehydrogenase, medium-chain acyl-coenzyme a dehydrogenase, octanoyl-CoA dehydrogenase, mcad enzyme
(26 Jun 1999)
medium vein <anatomy, vein> A vein characterised by having a thinner wall and larger lumen than its corresponding artery, and a media with small bundles of circular muscle separated by considerable connective tissue; valves also occur.
(05 Mar 2000)
growth medium <cell culture> A synthetic medium which is filled with nutrients necessary to the growth of microorganisms or cells being cultured in the lab.
(09 Oct 1997)
clearing medium A medium used in histology for making specimens translucent or transparent.
(05 Mar 2000)
minimal medium <cell culture> The simplest tissue culture medium that will support the proliferation of normal cells.
(18 Nov 1997)
cochleare medium A dessertspoonful.
Origin: L.
(05 Mar 2000)
motility test medium A culture medium with a concentration of agar that produces a less solid consistency than usual and allows motile organisms to grow away from the line of inoculation; used to differentiate species of bacteria.
(05 Mar 2000)
mounting medium <microscopy> Any liquid, polymer, resin, melt, or even gas used to mount microscopical specimens before examination. The chief attributes of a mounting medium are refractive index, viscosity, lack of colour and long-term chemical stability.
(05 Aug 1998)
complete medium <cell culture> A growth medium which supplies all of the nutrients and organic compounds necessary for a microorganism to grow, without forcing the microorganism to synthesise anything it needs on its own.
(05 Jan 1998)
complex medium <cell culture> A medium whose precise chemical composition is unknown.
Compare: defined medium.
(05 Jan 1998)
conditioned medium <cell biology> Cell culture medium that has already been partially used by cells. Although depleted of some components, it is enriched with cell derived material, probably including small amounts of growth factors, such cell conditioned medium will support the growth of cells at much lower density and, mixed with some fresh medium, is therefore useful in cloning.
(18 Nov 1997)
Mueller-Hinton medium An agar-based media composed of beef infusion, casamino acids, and starch useful in the isolation of gonococci and meningococci; the recommended medium for antibacterial susceptibility tests for most common aerobic and facultatively anaerobic bacteria.
(05 Mar 2000)
contrast medium A substance that is introduced into or around a structure and, because of the difference in absorption of X-rays by the contrast medium and the surrounding tissues, allows radiographic visualisation of the structure.
(18 Nov 1997)
HAT medium <cell biology, cell culture> A selective growth medium for animal tissue cells that contains Hypoxanthine, the folate antagonist Aminopterin (or amethopterin) and Thymine.
Used for selection of hybrid somatic cell lines, as in the production of monoclonal antibodies. In HAT medium, cells are forced to use these exogenous bases, via the salvage pathways, as their sole source of purines and pyrimidines.
Parental cells lacking enzymes such as HGPRT or TK can be eliminated whilst hybrids grow.
(18 Nov 1997)
Czapek-Dox medium A culture medium used for the cultivation of fungus species and for identification of Aspergillus and Penicillium species.
Synonym: Czapek-Dox medium.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • glass culture
    ¿Â½Ç Àç¹è
  • mental culture
    Á¤½Å¼ö¾ç
  • oyster culture
    ±¼¾ç½Ä(¾÷)
  • pop culture
    ´ëÁß ¹®È­;ÆÊÄÃó
  • pot culture
    ¸¶¶óÈ­³ª ¹®È­
  • pure culture
    (¹Ì»ý¹°ÀÇ) ¼ø¼ö ¹è¾ç
  • reverse culture shock
    ¿ª¹®È­ ¼îÅ©(¿Ü±¹¿¡¼­ ¿À·§µ¿¾È »ýȰÇÑ »ç¶÷ÀÌ °í±¹À¸·Î µ¹¾Æ¿ÔÀ» ¶§ ´À³¢´Â ¼Ò¿Ü°¨)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á